The increasing use of biomaterials and medical devices has led to the development of new families of diseases related precisely to the use of the biomaterials and medical devices themselves. Microbial contamination of the devices is a serious and widespread problem in surgery because it often causes devastating infections and loss of the implanted devices. The methods of contamination in medical devices are dependent on many peculiar factors including the chemistry of the biomaterial, the physical properties of the surface, the design of the medical device, the implanted anatomical site, the extension of surgical invasion, and the time of application. The environment and/or conditions and response of the host also contribute to the development of the colonization and infection. Many bacteria and fungi spp. are involved in biomaterial infections, but most belong to endogenous bacteria or the commensal community of the skin such as Staphylococcus epidermidis and Staphylococcus aureus. Medical device contamination always develops into biofilm formation, which constitutes a protected mode for the bacteria to survive in a hostile environment by optimizing nutrient uptake, as it is sheltered from the removal forces and is protected from the host defense mechanism and from potential toxic or harmful substances including antibiotics. Therefore, studies concerning infections related to implanted materials are of increasing frequency and interest. Both in vitro and in vivo studies are reported to simulate biomaterial infection. We report suggestions concerning useful standards and strategies to re-duce contamination on biomaterials. (Journal of Applied Biomaterials and Biomechanics 2005; 3: 1-10).
Download full-text PDF |
Source |
---|
J Intensive Care Soc
January 2025
Department of Physiotherapy, Faculty of Medicine, Dentistry and Health Sciences, School of Health Sciences, The University of Melbourne, Melbourne, VIC, Australia.
Digital health refers to the field of using and developing technology to improve health outcomes. Digital health and digital health interventions (DHIs) within the area of intensive care and critical illness survivorship are rapidly evolving. Digital health interventions refer to technologies in clinical interventional format.
View Article and Find Full Text PDFFront Health Serv
December 2024
Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, United States.
Introduction: Clinicians are the conduits of high-quality care delivery. Clinicians have driven advancements in pharmacotherapeutics, devices, and related interventions and improved morbidity and mortality in patients with congestive heart failure over the past decade. Yet, the management of congestive heart failure has become extraordinarily complex and has fueled recommendations from the American Heart Association and the American College of Cardiology to optimize the composition of the care team to reduce the health, economic, and the health system burden of high lengths of stay and hospital charges.
View Article and Find Full Text PDFFront Vet Sci
December 2024
Department of Veterinary Clinical Science, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Republic of Korea.
Introduction: The objective of this study is to analyze the morphology and measurement dimensions of patent ductus arteriosus (PDA) based on computed tomography images.
Methods: The present study retrospectively evaluated computed tomography angiography data from 25 client-owned dogs diagnosed with PDA. PDA was reconstructed based on the central axis and the minimum diameter, ampulla diameter, angle, ampulla cross-section area, and length values were measured at specific measurement sites.
Front Neurol
December 2024
Sense4Care, Cornellà de Llobregat, Spain.
Parkinson's disease (PD) is a neurodegenerative disorder that significantly impacts patients' quality of life. Managing PD requires accurate assessment of motor and non-motor symptoms, often complicated by the subjectivity in symptom reporting and the limited availability of neurologists. To address these challenges, commercial wearable devices have emerged to continuously monitor PD symptoms outside the clinical setting.
View Article and Find Full Text PDFLeft ventricular assist devices (LVADs) have been used as a bridge to transplantation in patients with advanced heart failure. In this case, LVAD therapy was used as a destination therapy for 16 years, representing the longest documented and continuously ongoing support with the original implanted device.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!